CARE NSW trial for advanced cancer patients now recruiting

In February 2020, recruitment commenced for the CARE NSW trial (Cannabinoids for Symptom Control in Advanced Cancer, an Open Label Prospective Clinical Trial in NSW). 

The first site to begin recruiting patients was Orange Health Service, and additional centres across regional and metropolitan NSW have since commenced recruiting. A list of the current trial sites can be found on the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE) website. 

CARE NSW is a state-wide clinical trial funded by the NSW Government. Up to 600 patients in NSW who experience pain, nausea and anorexia as a symptom of their advanced cancer will be enrolled. The trial aims to identify what dose and frequency of cannabis medicines is best for symptom control in patients with advanced cancer.  

The trial is being led by Professor Jennifer Martin, Clinical Pharmacologist, General Physician and Director of ACRE, based at the University of Newcastle, alongside a research team of specialists in palliative care, public health, addiction medicine, pharmacology and toxicology.  

For further information about the trial, including the eligibility criteria, see: